Takeda gets Japanese approval for $62 billion Shire purchase

17:21 18 October 2018
Takeda gets Japanese approval for $62 billion Shire purchase

Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoon 

 

Takeda Pharmaceutical Co Ltd  said on Thursday Japan’s Fair Trade Commission had approved its $62 billion acquisition of Shire Plc, bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker.

The deal, which will be the largest overseas purchase by a Japanese company, has already received unconditional clearance from regulators in the United States, Brazil and China.

“Takeda is proud of its Japanese heritage, and we are looking forward to building on this heritage as a combined company to continue delivering highly-innovative medicines that are transformative to patients in Japan and around the world,” Takeda CEO Christophe Weber said in a statement.

Takeda is also waiting for a nod from EU antitrust regulators. They are expected to make a decision by Nov. 6 but can open a four-month long investigation if they have serious concerns.

 

Reuters.com

Related Posts
TOP-5
Курсы валют
Курсы валют
Курсы валют
Converter
UAH
25.03
RUB
65.51
EUR
1.15
The ratio of currency you can view here https://www.forexpf.ru/

User Reviews

Я купил небольшой СТО, в штате всего пять человек, но он работает. Я очень благодарен вам.
Артем Михайлович
Ich habe meinen Laden verkauft, als ich ins Ausland ging. Der Käufer wurde überraschend schnell gefunden und die Transaktion verlief relativ reibungslos.
Elena
Я не знаю, как вы решили создать такой сайт, но я очень рад работать с вами. Большое спасибо.
Максим


Add a Review
Registration
Forgot Password?
Business - is our main product
© 2015-2019. All rights reserved. Copying materials from the site must provide a reciprocal link. Sitemap
Web-agency